| Pharmaceutical active ingredients: |
| Salicylic Acid |
| Available forms, composition and doses of Salac: |
| Liquid; Topical; Salicylic Acid 2% |
| Salac medical category: |
| Human:Acne treatment preparationsAntidandruff productsAntiseptic skin cleansersKeratolytic agentsMiscellaneous local anti-infectives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D02AF - Salicylic Acid preparations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Medicis Pharmaceutical Corporation |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Pentrax | Coal Tar | Medicis Pharmaceutical Corporation; Alliance Pharmaceuticals; Johnson & Johnson; United Drug |
| Pentrax Gold | Coal Tar | Medicis Pharmaceutical Corporation |
| Pentrax Tar | Coal Tar | Medicis Pharmaceutical Corporation |
| Plexion | Sulfacetamide Sodium; Sulfur | Medicis Pharmaceutical Corporation |
| Restylane | Hyaluronic Acid | Medicis Pharmaceutical Corporation; Q-Med ICT |
| Solodyn | Minocycline Hydrochloride | Medicis Pharmaceutical Corporation; WellSpring Pharmaceuticals |
| Step 2 | Benzyl Alcohol; Formic Acid | Medicis Pharmaceutical Corporation |
| Synalar | Fluocinolone Acetonide | Medicis Pharmaceutical Corporation; AFT Pharmaceuticals; Agencia Lei Va Hong; Astellas Pharma; AstraZeneca; Bioglan; Biomed, Singapore; Derma UK; DKSH; Edward Keller; Grunenthal; Janssen; Jolly Jatel Laboratoire; Minerva Pharmaceutical; Pharmed Import & Export; Sanofi-Aventis; Syntex; United Italian Trading; V.J. Bartlett; Valeo Pharma; Ventiv Health Magyarorszag; Yamanouchi |
| Synalar + DBO | Broxyquinoline; Fluocinolone Acetonide | Medicis Pharmaceutical Corporation; Roche; Syntex |
| Synalar Bi-Ophtalmic | Fluocinolone Acetonide; Neomycin Sulfate; Polymyxin B Sulfate | Medicis Pharmaceutical Corporation; GlaxoSmithKline |